4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-006496
CEO gave up 3,277 shares (to pay taxes)
- CEO acquired 9,466 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal CEO | 2025-03-01 | Option exercise | +9,466 | 1,470,184 | D | ||
| Walker Neal CEO | 2025-03-01 | Shares withheld for taxes | −3,277 | $1.99 | $6,521 | 1,466,907 | D |
| Derivatives | |||||||
| Walker Neal CEO | 2025-03-01 | Option exercise · Restricted Stock Units | −9,466 | 18,934 | D | ||
Loading xslF345X05/form4-03042025_040312.xml…